Name | o-(7-Azabenzotriazol-1-yl)-N,N,N',N'-te-tramethyluronium hexafluorophosphate |
Synonyms | HATU O-(7-AZABENZOTRIAZOL-1-YL)URONIUM HEXAFLUORO-PHOSPHATE O-(7-AZABENZOTRIAZOL-1-YL)-1,1,3,3-TETRAMETHYLURONIUM HEXAFLUOROPHOSPHATE N,N,N',N'-TETRAMETHYL-O-(7-AZABENZOTRIAZOL-1-YL)URONIUM HEXAFLUOROPHOSPATE N,N,N',N'-Tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophospate O-(7-Azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 2-(7-Azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate O-(7-AZABENZOTRIAZOL-1-YL)-N,N,N',N'-TETRAMETHYLURONIUM HEXAFLUOROPHOSPHATE o-(7-Azabenzotriazol-1-yl)-N,N,N',N'-te-tramethyluronium hexafluorophosphate O-(7-AZABENZOTRIAZOLE-1-YL)-N, N,N',N'-TETRAMETHYLURONIUM HEXAFLUOROPHOSPHATE 2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate O-(7-Aza-1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate, ChemDoseTM tablets N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylidene]-N-methylmethanaminium hexafluorophosphate N-[(dimethylamino)(3-oxido-1H-[1,2,3]triazolo[4,5-b]pyridin-1-yl)methylidene]-N-methylmethanaminium hexafluorophosphate |
CAS | 148893-10-1 |
EINECS | 604-662-7 |
InChI | InChI=1/C10H15N6O.F6P/c1-14(2)10(15(3)4)17-16-9-8(12-13-16)6-5-7-11-9;1-7(2,3,4,5)6/h5-7H,1-4H3;/q+1;-1 |
InChIKey | KZAWCZZRROLLDL-UHFFFAOYSA-N |
Molecular Formula | C10H15F6N6OP |
Molar Mass | 380.24 |
Melting Point | 183-188°C (dec.) |
Boling Point | 176℃ at 760mmHg |
Water Solubility | Soluble in acetonitrile. Insoluble in water. |
Solubility | Soluble in Acetone and DMSO |
Appearance | White crystalline powder |
Color | White to Almost white |
Storage Condition | 2-8°C |
Sensitive | Thermal sensitivity |
MDL | MFCD00274639 |
Physical and Chemical Properties | Melting point 183-185°C |
Use | This product is for scientific research only and shall not be used for other purposes. |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R2 - Risk of explosion by shock, friction, fire or other sources of ignition |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S37/39 - Wear suitable gloves and eye/face protection S36/37 - Wear suitable protective clothing and gloves. S36 - Wear suitable protective clothing. S35 - This material and its container must be disposed of in a safe way. |
UN IDs | 1325 |
WGK Germany | 3 |
RTECS | XZ5633000 |
FLUKA BRAND F CODES | 10-21 |
HS Code | 29339999 |
Hazard Class | 4.1 |
Packing Group | Ⅱ |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
introduction | HATU is a commonly used polypeptide condensation reagent, which is used in the reaction of carboxyl group and amino group to synthesize peptide bond. |
uses | pharmaceutical intermediates and polypeptide condensation reagents. For solid-phase polypeptide synthesis, recent studies have shown that the crystallization or solution of this coupling reagent results in the N-oxide form of guanidine (guanidinium N-oxide), rather than a urine compound. Peptide coupling reagent; use solid-phase synthesis method to prepare N-arylsulfonamide-linked peptides; the latest research shows that the crystal and solution structure of the coupling agent is guanidine salt N-oxide, not urea cationic compound; effective coupling agent in solid-phase peptide synthesis |